Friday, 29 September 2017

U.S. FDA approves Novo Nordisk fast-acting insulin Fiasp

(Reuters) - The U.S. Food and Drug Administration on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)